JPH10509729A - 骨粗鬆症治療サイクル用キット - Google Patents

骨粗鬆症治療サイクル用キット

Info

Publication number
JPH10509729A
JPH10509729A JP8517359A JP51735996A JPH10509729A JP H10509729 A JPH10509729 A JP H10509729A JP 8517359 A JP8517359 A JP 8517359A JP 51735996 A JP51735996 A JP 51735996A JP H10509729 A JPH10509729 A JP H10509729A
Authority
JP
Japan
Prior art keywords
tiludronic acid
pharmaceutically acceptable
nutritional supplement
calcium
kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP8517359A
Other languages
English (en)
Japanese (ja)
Inventor
ガザール，マルティーヌ
グロ，オリヴィエ
ジラール，ジャック
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of JPH10509729A publication Critical patent/JPH10509729A/ja
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
JP8517359A 1994-12-06 1995-12-05 骨粗鬆症治療サイクル用キット Ceased JPH10509729A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR94/14630 1994-12-06
FR9414630A FR2727629A1 (fr) 1994-12-06 1994-12-06 Trousse pour cycle de traitement de l'osteoporose
PCT/FR1995/001596 WO1996017616A1 (fr) 1994-12-06 1995-12-05 Trousse pour cycle de traitement de l'osteoporose

Publications (1)

Publication Number Publication Date
JPH10509729A true JPH10509729A (ja) 1998-09-22

Family

ID=9469504

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8517359A Ceased JPH10509729A (ja) 1994-12-06 1995-12-05 骨粗鬆症治療サイクル用キット

Country Status (20)

Country Link
EP (1) EP0797444A1 (enrdf_load_stackoverflow)
JP (1) JPH10509729A (enrdf_load_stackoverflow)
KR (1) KR980700083A (enrdf_load_stackoverflow)
CN (1) CN1168634A (enrdf_load_stackoverflow)
AR (1) AR002946A1 (enrdf_load_stackoverflow)
AU (1) AU4307396A (enrdf_load_stackoverflow)
BR (1) BR9509961A (enrdf_load_stackoverflow)
CA (1) CA2207028A1 (enrdf_load_stackoverflow)
CZ (1) CZ175397A3 (enrdf_load_stackoverflow)
FI (1) FI972383A0 (enrdf_load_stackoverflow)
FR (1) FR2727629A1 (enrdf_load_stackoverflow)
HU (1) HUT77382A (enrdf_load_stackoverflow)
IL (1) IL116168A0 (enrdf_load_stackoverflow)
MA (1) MA23737A1 (enrdf_load_stackoverflow)
NO (1) NO972558L (enrdf_load_stackoverflow)
PL (1) PL320564A1 (enrdf_load_stackoverflow)
SK (1) SK68597A3 (enrdf_load_stackoverflow)
TR (1) TR199501530A1 (enrdf_load_stackoverflow)
WO (1) WO1996017616A1 (enrdf_load_stackoverflow)
ZA (1) ZA9510184B (enrdf_load_stackoverflow)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6432932B1 (en) 1997-07-22 2002-08-13 Merck & Co., Inc. Method for inhibiting bone resorption
US5994329A (en) 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption
SI1506041T1 (sl) 2002-05-10 2008-02-29 Hoffmann La Roche Ibandronska kislina za zdravljenje in preprecevanje osteoporoze
CA2484494C (en) * 2002-12-20 2009-05-12 F. Hoffmann-La Roche Ag High dose ibandronate formulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE66608T1 (de) * 1984-04-30 1991-09-15 Procter & Gamble Ausruestung fuer die behandlung der osteoporose.
US4761406A (en) * 1985-06-06 1988-08-02 The Procter & Gamble Company Regimen for treating osteoporosis
JP4481368B2 (ja) * 1992-06-30 2010-06-16 味の素株式会社 骨粗鬆症の治療用のためのホスホネート類の用途
FR2694558B1 (fr) * 1992-08-05 1994-10-28 Sanofi Elf Monohydrate du sel disodique de l'acide 4-chlorophénylthiométhylène bisphosphonique, sa préparation, les compositions pharmaceutiques en contenant.

Also Published As

Publication number Publication date
BR9509961A (pt) 1997-11-25
AR002946A1 (es) 1998-05-27
WO1996017616A1 (fr) 1996-06-13
FR2727629A1 (fr) 1996-06-07
CA2207028A1 (en) 1996-06-13
EP0797444A1 (fr) 1997-10-01
ZA9510184B (en) 1996-06-11
TR199501530A1 (tr) 1996-10-21
PL320564A1 (en) 1997-10-13
MA23737A1 (fr) 1996-07-01
FI972383L (fi) 1997-06-05
FR2727629B1 (enrdf_load_stackoverflow) 1997-02-28
FI972383A7 (fi) 1997-06-05
SK68597A3 (en) 1997-11-05
MX9704105A (es) 1997-09-30
IL116168A0 (en) 1996-01-31
HUT77382A (hu) 1998-04-28
KR980700083A (ko) 1998-03-30
FI972383A0 (fi) 1997-06-05
NO972558D0 (no) 1997-06-05
NO972558L (no) 1997-08-05
CZ175397A3 (en) 1997-10-15
CN1168634A (zh) 1997-12-24
AU4307396A (en) 1996-06-26

Similar Documents

Publication Publication Date Title
US20050026871A1 (en) Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin D derivative
US20030158154A1 (en) Dosage forms for immediate gastric release of a calcium transport stimulator coupled with delayed gastric release of a bis-phosphonate
US4904478A (en) Slow-release sodium fluoride tablet and method for treatment of osteoporosis
JP2002509883A (ja) フマル酸アルキル水素エステルからなる乾癬、乾癬性関節炎、神経皮膚炎および限局性回腸炎クローン病の治療剤
JP2659968B2 (ja) フッ素とカルシウムの持続放出組成物
JP2594576B2 (ja) 持続性放出フッ化物組成物
CA2671727C (en) A composition containing a bisphosphonic acid in combination with vitamin d
JP6374879B2 (ja) 骨粗しょう症治療用の安定な医薬組成物
US5013728A (en) Composition for treating osteoporosis and hormonal imbalance
EP1651191B1 (en) Effervescent pharmaceutical compositions containing vitamin d, calcium and phospate and their therapeutic use
EP0521057A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING IPRIFLAVONE, PROCESS FOR THE PREPARATION AND PHARMACEUTICAL USES OF THESE COMPOSITIONS.
JPH0699310B2 (ja) アセトアルデヒド解毒剤
JPH10509729A (ja) 骨粗鬆症治療サイクル用キット
WO2015001329A1 (en) Chewable tablet
MXPA97004105A (en) Set for use in a therapeutic treatment cycle of osteoporo
HU211084B (en) Process for producing oral pharmaceutical composition of bone strengthening activity
WO2000044385A1 (en) Pharmaceutical combination of progesterone and folic acid
JP2020029404A (ja) 腸溶性組成物及びその製造方法
HK1182623A (en) A composition containing a bisphosphonic acid in combination with vitamin d
AU2014215992A1 (en) A composition containing a bisphosphonic acid in combination with vitamin D
JPH0259516A (ja) 薬剤送達用組成物
WO2005123052A1 (fr) Composition medicamenteuse contenant de l'ambroxol et de l'erdosteine ou de l'acetylcysteine
KR19990056903A (ko) 입덧 치료제

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040323

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20040623

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20040809

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20041101

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20041207